LambdaVision Incorporated
5 known investors
LambdaVision develops a protein-based artificial retina to restore vision in patients with advanced retinal degenerative diseases such as retinitis pigmentosa and age-related macular degeneration. The technology uses proteins similar to natural visual pigments to replace the function of damaged retinal cells.